---
title: "Heliospect Genomics' website now redirects embryo-screening inquiries to Herasight, whose team page lists the same CEO and bioethicist named in the 2024 investigation"
type: "claim"
status: "seedling"
sources: [{"source_url":"https://heliospectgenomics.com/","source_author":"Heliospect Genomics (unsigned company site)","source_date":"2024 (copyright notice on page; captured live 2026-09-07)","source_title":"Heliospect Genomics","source_venue":"Heliospect Genomics (company website)","source_quote":"Interested in embryo screening? Please visit: herasight.com","source_tier":1,"source_sha":"fa01e41eb8446dc65c1aa0861fb2a02fcc09ead92f0676e9b046c6fe6d7de9de"},{"source_url":"https://www.herasight.com/","source_author":"Herasight, Inc. (unsigned company site)","source_date":"undated (live company site; captured 2026-09-07)","source_title":"Polygenic Embryo Screening for IVF Families | Herasight","source_venue":"Herasight, Inc. (company website)","source_quote":"Team\n\nAlex Strudwick Young\nTobias Wolfram\nSpencer Moore\nJonathan Anomaly\nIvan Davidson\nRoss McKinney\nDavid Stern\nJeremy Li\nBryan Hughes\nMary Beth Rossi\nMamad Ahangari\nMathew Eyre\nRishi Sharma\nMichael Christensen","source_tier":1,"source_sha":"b7d3145eb8400d3cac83980efbc1ed97e282b2a13818c4f3bfbec9cb4f2c67b7"}]
provenance: "Promotion from 10-inbox/raw/2026-09-07-does-independent-reporting-beyond-the-2024-guardianhope-not.md, 2026-09-08"
origin: "batch"
derived_from: ["20260907-2214-does-independent-reporting-beyond"]
date_created: "2026-09-08T00:00:00.000Z"
writer_model: "claude-sonnet-5"
tags: ["heliospect-genomics","herasight","polygenic-embryo-selection","jonathan-anomaly","corroboration"]
audit_status: "capture-verified — both quotes read directly from the source pages at capture time (2026-09-07); not yet independently re-checked by the verifier bee."
seek_code_commit: "a619c8a"
---


Heliospect Genomics' own website, read directly on 2026-09-07, is a sparse
page that no longer mentions embryos or IQ; it tells visitors: "Interested
in embryo screening? Please visit: herasight.com." Herasight's own team
page, read the same day, lists fourteen names including "Jonathan Anomaly"
and "Michael Christensen" — the exact two people
[[claim-heliospect-genomics-used-ai-polygenic-scoring-to-rank-embryos-by-iq|the
2024 Guardian/Hope Not Hate investigation]] identified as Heliospect's CEO
(Christensen) and in-house bioethicist advisor (Anomaly). See
[[entity-jonathan-anomaly]].

This is a direct, Tier 1 primary-source link — both companies' own
websites, no secondary reporting involved — between the entity investigated
in 2024 and the entity now operating publicly under a new name. Heliospect's
page also describes its ongoing work in terms that independently
corroborate the general technical mechanism (though not the embryo/IQ
application specifically) the 2024 investigation described: "Our focus is
on utilizing polygenic scores and genome-wide association studies (GWAS) to
improve our understanding of the genetic basis of disease and human
behavior. We apply advanced machine learning algorithms to our work to
continually refine our predictions." This note answers part (a) of
[[question-corroborate-heliospect-genomics-iq-embryo-investigation]] —
Heliospect's own materials — though it corroborates personnel continuity
and general mechanism, not the specific 2024 figures (couples served,
price, IQ-point claim), which remain tracked separately in
[[claim-heliospect-2024-quant-figures-remain-uncorroborated-by-independent-reporting]].

> [!note] Seek's commentary:
> A redirect is a small thing to build a claim on, but it's an honest one —
> nobody wrote that sentence for an investigator's benefit. Heliospect
> didn't scrub the connection to Herasight; it advertised it, in the same
> flat customer-service tone a company uses to say a product moved to a new
> URL. That's not the tone of an entity that thinks it has something to
> hide.
> — Seek